The σ receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex

Jane E. Roth, Paul H. Franklin, Thomas F. Murray

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Unilateral focal injection of 1,3-di(2-tolyl)guanidine (DTG) caused a dose-dependent and potent (ED50 = 5.25 nmol, 95% confidence limits 1.1 to 25.0 nmol) suppression of generalized motor seizures induced by (-)-bicuculline methiodide in the rat prepiriform cortex. These findings indicate that DTG is equipotent to the noncompetitive NMDA receptor antagonist MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate) as an anticonvulsant. This potent pharmacological effect of DTG distinguishes it from two other prototypic σ ligands, haloperidol and (+)-pentazocine, which are ineffective as anticonvulsants. Pretreatment of animals with haloperidol failed to block the anticonvulsant effects of DTG. These data therefore document a novel anticonvulsant action of DTG in vivo by a mechanism that does not involve σ receptors.

Original languageEnglish
Pages (from-to)327-331
Number of pages5
JournalEuropean Journal of Pharmacology
Volume236
Issue number2
DOIs
StatePublished - May 19 1993
Externally publishedYes

Fingerprint

Anticonvulsants
Ligands
Haloperidol
Seizures
Pentazocine
Imines
Dizocilpine Maleate
N-Methyl-D-Aspartate Receptors
Pharmacology
Injections
Piriform Cortex
1,3-ditolylguanidine

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

The σ receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex. / Roth, Jane E.; Franklin, Paul H.; Murray, Thomas F.

In: European Journal of Pharmacology, Vol. 236, No. 2, 19.05.1993, p. 327-331.

Research output: Contribution to journalArticle

@article{7cacfa034f754c05b752e0e5554b67fa,
title = "The σ receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex",
abstract = "Unilateral focal injection of 1,3-di(2-tolyl)guanidine (DTG) caused a dose-dependent and potent (ED50 = 5.25 nmol, 95{\%} confidence limits 1.1 to 25.0 nmol) suppression of generalized motor seizures induced by (-)-bicuculline methiodide in the rat prepiriform cortex. These findings indicate that DTG is equipotent to the noncompetitive NMDA receptor antagonist MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate) as an anticonvulsant. This potent pharmacological effect of DTG distinguishes it from two other prototypic σ ligands, haloperidol and (+)-pentazocine, which are ineffective as anticonvulsants. Pretreatment of animals with haloperidol failed to block the anticonvulsant effects of DTG. These data therefore document a novel anticonvulsant action of DTG in vivo by a mechanism that does not involve σ receptors.",
author = "Roth, {Jane E.} and Franklin, {Paul H.} and Murray, {Thomas F.}",
year = "1993",
month = "5",
day = "19",
doi = "10.1016/0014-2999(93)90607-J",
language = "English",
volume = "236",
pages = "327--331",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - The σ receptor ligand 1,3-di(2-tolyl)guanidine is anticonvulsant in the rat prepiriform cortex

AU - Roth, Jane E.

AU - Franklin, Paul H.

AU - Murray, Thomas F.

PY - 1993/5/19

Y1 - 1993/5/19

N2 - Unilateral focal injection of 1,3-di(2-tolyl)guanidine (DTG) caused a dose-dependent and potent (ED50 = 5.25 nmol, 95% confidence limits 1.1 to 25.0 nmol) suppression of generalized motor seizures induced by (-)-bicuculline methiodide in the rat prepiriform cortex. These findings indicate that DTG is equipotent to the noncompetitive NMDA receptor antagonist MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate) as an anticonvulsant. This potent pharmacological effect of DTG distinguishes it from two other prototypic σ ligands, haloperidol and (+)-pentazocine, which are ineffective as anticonvulsants. Pretreatment of animals with haloperidol failed to block the anticonvulsant effects of DTG. These data therefore document a novel anticonvulsant action of DTG in vivo by a mechanism that does not involve σ receptors.

AB - Unilateral focal injection of 1,3-di(2-tolyl)guanidine (DTG) caused a dose-dependent and potent (ED50 = 5.25 nmol, 95% confidence limits 1.1 to 25.0 nmol) suppression of generalized motor seizures induced by (-)-bicuculline methiodide in the rat prepiriform cortex. These findings indicate that DTG is equipotent to the noncompetitive NMDA receptor antagonist MK-801 ((+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine hydrogen maleate) as an anticonvulsant. This potent pharmacological effect of DTG distinguishes it from two other prototypic σ ligands, haloperidol and (+)-pentazocine, which are ineffective as anticonvulsants. Pretreatment of animals with haloperidol failed to block the anticonvulsant effects of DTG. These data therefore document a novel anticonvulsant action of DTG in vivo by a mechanism that does not involve σ receptors.

UR - http://www.scopus.com/inward/record.url?scp=0027241086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027241086&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(93)90607-J

DO - 10.1016/0014-2999(93)90607-J

M3 - Article

VL - 236

SP - 327

EP - 331

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2

ER -